Mon, June 24, 2019
Fri, June 21, 2019
Thu, June 20, 2019
Wed, June 19, 2019
Tue, June 18, 2019
Mon, June 17, 2019
Fri, June 14, 2019
Thu, June 13, 2019

Jason McCarthy Upgraded (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019

Jason McCarthy of Maxim Group, Upgraded "bluebird bio, Inc." (BLUE) to Strong Buy and Held Target at $160 on, Jun 18th, 2019.

Jason has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Tuesday, March 5th, 2019


These are the ratings of the 2 analyists that currently disagree with Jason


  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $163 on, Monday, June 17th, 2019
  • Yaron Werber of "Cowen & Co." Initiated at Buy on, Tuesday, February 26th, 2019